Compare NPCE & ASTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPCE | ASTL |
|---|---|---|
| Founded | 1997 | 1902 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.3M | 467.0M |
| IPO Year | 2021 | N/A |
| Metric | NPCE | ASTL |
|---|---|---|
| Price | $15.51 | $4.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $18.33 | N/A |
| AVG Volume (30 Days) | 165.9K | ★ 1.1M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | ★ 29.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $99,986,000.00 | N/A |
| Revenue This Year | $0.90 | N/A |
| Revenue Next Year | $24.46 | $24.62 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.13 | N/A |
| 52 Week Low | $7.56 | $3.02 |
| 52 Week High | $18.97 | $7.25 |
| Indicator | NPCE | ASTL |
|---|---|---|
| Relative Strength Index (RSI) | 61.87 | 61.72 |
| Support Level | $15.25 | $4.29 |
| Resistance Level | $15.71 | $5.25 |
| Average True Range (ATR) | 0.67 | 0.22 |
| MACD | 0.22 | 0.10 |
| Stochastic Oscillator | 90.80 | 76.69 |
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.